Cancer and systemic sclerosis: novel insights into pathogenesis and clinical implications

gan Shah, Ami A., Rosen, Antony
Cyhoeddwyd 2011

Management of incidental esophageal uptake on FDG PET/CT

gan Shah, Ami A, Wu, Jennifer
Cyhoeddwyd 2014

My Approach to the Treatment of Scleroderma

gan Shah, Ami A., Wigley, Fredrick M.
Cyhoeddwyd 2013

Cancer and Scleroderma: A Paraneoplastic Disease with Implications for Malignancy Screening

gan Shah, Ami A., Rosen, Livia Casciola
Cyhoeddwyd yn Curr Opin Rheumatol (2015)

Mechanistic and clinical insights at the scleroderma-cancer interface

gan Shah, Ami A., Casciola-Rosen, Livia
Cyhoeddwyd yn J Scleroderma Relat Disord (2017)

More than Skin Deep: Bringing Precision Medicine to Systemic Sclerosis

gan Mecoli, Christopher A., Shah, Ami A.
Cyhoeddwyd yn Arthritis Rheumatol (2020)

The relationships between cancer and autoimmune rheumatic diseases

gan Cappelli, Laura C., Shah, Ami A.
Cyhoeddwyd yn Best Pract Res Clin Rheumatol (2020)

Cancer and Autoimmunity: Harnessing Longitudinal Cohorts to Probe the Link

gan Egiziano, Giordano, Bernatsky, Sasha, Shah, Ami A.
Cyhoeddwyd yn Best Pract Res Clin Rheumatol (2016)

Review: Cancer‐Induced Autoimmunity in the Rheumatic Diseases

gan Shah, Ami A., Casciola‐Rosen, Livia, Rosen, Antony
Cyhoeddwyd yn Arthritis Rheumatol (2015)

Cancer and scleroderma

gan Weeding, Emma, Casciola-Rosen, Livia, Shah, Ami A.
Cyhoeddwyd yn Rheum Dis Clin North Am (2020)

Telangiectases in Scleroderma: A Potential Clinical Marker of Pulmonary Arterial Hypertension

gan Shah, Ami A., Wigley, Fredrick M., Hummers, Laura K.
Cyhoeddwyd 2009

Cancer immunotherapy-induced rheumatic diseases emerge as new clinical entities

gan Cappelli, Laura C, Shah, Ami A, Bingham, Clifton O
Cyhoeddwyd yn RMD Open (2016)

Immune-related adverse effects of cancer immunotherapy- Implications for rheumatology

gan Cappelli, Laura C., Shah, Ami A., Bingham, Clifton O.
Cyhoeddwyd yn Rheum Dis Clin North Am (2016)

Scleroderma patients with antibodies against the large subunits of both RNA polymerases-I and -III are protected against cancer

gan Shah, Ami A., Laiho, Marikki, Rosen, Antony, Casciola-Rosen, Livia
Cyhoeddwyd yn Arthritis Rheumatol (2019)

Response to: ‘“Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation” by Braaten et al: another point of view’ by Cappelli et al

gan Cappelli, Laura C, Bingham, Clifton O, Braaten, Tawnie, Shah, Ami A
Cyhoeddwyd yn Ann Rheum Dis (2020)

Advances at the interface of cancer and systemic sclerosis

gan Mecoli, Christopher A, Rosen, Antony, Casciola-Rosen, Livia, Shah, Ami A
Cyhoeddwyd yn J Scleroderma Relat Disord (2020)

Close Temporal Relationship Between Onset of Cancer and Scleroderma in Patients with RNA Polymerase I/III Antibodies

gan Shah, Ami A., Rosen, Antony, Hummers, Laura, Wigley, Fredrick, Casciola-Rosen, Livia
Cyhoeddwyd 2010

Rheumatic and musculoskeletal immune-related adverse events due to immune checkpoint inhibitors: A systematic review of the literature

gan Cappelli, Laura C., Gutierrez, Anna Kristina, Bingham, Clifton O., Shah, Ami A.
Cyhoeddwyd yn Arthritis Care Res (Hoboken) (2017)

Sonographic Findings in Inflammatory Arthritis Secondary to Immune Checkpoint Inhibition: A Case Series

gan Albayda, Jemima, Dein, Eric, Shah, Ami A., Bingham, Clifton O., Cappelli, Laura
Cyhoeddwyd yn ACR Open Rheumatol (2019)

Metastatic joint involvement or inflammatory arthritis? A conundrum with immune checkpoint inhibitor-related adverse events

gan Albayda, Jemima, Bingham, Clifton O, Shah, Ami A, Kelly, Ronan J, Cappelli, Laura
Cyhoeddwyd yn Rheumatology (Oxford) (2018)